Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Akums Drugs and Pharmaceuticals Limited ( (IN:AKUMS) ) has provided an announcement.
Akums Drugs and Pharmaceuticals Limited has entered into a Framework Agreement with the Government of the Republic of Zambia to establish a local manufacturing facility in Zambia. This joint venture, where Akums will hold a 51% stake, aims to support Zambia’s national health programs and enhance local production capabilities, with plans to export to neighboring countries. The facility is expected to start manufacturing in 2028, producing a range of pharmaceutical products, while the Zambian government will purchase medicines worth USD 50 million from the joint venture over two years until the facility becomes operational.
More about Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited is a leading contract development and manufacturing company in India, engaged in the development and manufacture of pharmaceutical products across a wide range of therapeutic areas. The company is recognized for its contribution to pharmaceutical innovation and excellence.
Average Trading Volume: 17,192
Technical Sentiment Signal: Strong Sell
Current Market Cap: 75.37B INR
Learn more about AKUMS stock on TipRanks’ Stock Analysis page.